Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of HDAC and Signal Transduction Pathways Induces Tight Junctions and Promotes Differentiation in p63-Positive Salivary Duct Adenocarcinoma. | Cancers (Basel) | 2022 | 35681564 | PubTator, text mining | PubMed |
| Molecular Oncology of Bladder Cancer from Inception to Modern Perspective. | Cancers (Basel) | 2022 | 35681556 | PubTator, text mining | PubMed |
| Homoharringtonine is a transdermal granular permeation enhancer. | Biochem Biophys Res Commun | 2022 | 35679696 | PubTator, text mining | PubMed |
| Potential roles of claudin-3 and claudin-4 in ovarian cancer management. | J Egypt Natl Canc Inst | 2022 | 35665865 | PubTator, text mining | PubMed |
| EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity. | Genes Chromosomes Cancer | 2022 | 35665561 | PubTator, text mining | PubMed |
| Integrating spatial transcriptomics with single-cell transcriptomics reveals a spatiotemporal gene landscape of the human developing kidney. | Cell Biosci | 2022 | 35659756 | PubTator, text mining | PubMed |
| Tight junction channels claudin-10b and claudin-15: Functional mapping of pore-lining residues. | Ann N Y Acad Sci | 2022 | 35650657 | PubTator, text mining | PubMed |
| Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy. | Biomark Res | 2022 | 35642043 | PubTator, text mining | PubMed |
| Does freeze dried amnion useful as scaffold for mesenchymal stem cell for repair of vesicovaginal fistula? An overview of proliferative and remodeling phase in the wound healing process. | Eur J Obstet Gynecol Reprod Biol | 2022 | 35640439 | PubTator, text mining | PubMed |
| Polycomb repressive complex 2 shields naïve human pluripotent cells from trophectoderm differentiation. | Nat Cell Biol | 2022 | 35637409 | PubTator, text mining | PubMed |
| Effect of Humantenine on mRNA m6A Modification and Expression in Human Colon Cancer Cell Line HCT116. | Genes (Basel) | 2022 | 35627166 | PubTator, text mining | PubMed |
| Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. | Biomolecules | 2022 | 35625579 | PubTator, text mining | PubMed |
| Vitamin D3 Nutritional Status Affects Gut Health of Salmonella-Challenged Laying Hens. | Front Nutr | 2022 | 35619956 | PubTator, text mining | PubMed |
| Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231. | Mol Biomed | 2022 | 35614362 | PubTator, text mining | PubMed |
| Burn Injury-Induced Extracellular Vesicle Production and Characteristics. | Shock | 2022 | 35613455 | PubTator, text mining | PubMed |
| Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. | Sci Rep | 2022 | 35595817 | PubTator, text mining | PubMed |
| Effects of different short-chain fatty acids (SCFA) on gene expression of proteins involved in barrier function in IPEC-J2. | Porcine Health Manag | 2022 | 35590351 | PubTator, text mining | PubMed |
Mechanism of Peitu Shengjin Formula Shenlingbaizhu Powder in Treating Bronchial Asthma and Allergic Colitis through Different Diseases with Simultaneous Treatment Based on Network Pharmacology and Molecular Docking. | Evid Based Complement Alternat Med | 2022 | 35586697 | PubTator, text mining | PubMed |
| Conventional and Nonconventional Sources of Exosomes-Isolation Methods and Influence on Their Downstream Biomedical Application. | Front Mol Biosci | 2022 | 35586196 | PubTator, text mining | PubMed |
| Cytomorphology of nodular histiocytic/mesothelial hyperplasia. | Diagn Cytopathol | 2022 | 35582754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=47